These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 34689071)

  • 1. The nano delivery systems and applications of mRNA.
    Li M; Li Y; Li S; Jia L; Wang H; Li M; Deng J; Zhu A; Ma L; Li W; Yu P; Zhu T
    Eur J Med Chem; 2022 Jan; 227():113910. PubMed ID: 34689071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of lipid constituents in lipid nanoparticle mRNA delivery systems.
    Wu S; Lin L; Shi L; Liu S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(4):e1978. PubMed ID: 38965928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
    Qiu M; Li Y; Bloomer H; Xu Q
    Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What Do COVID-19 Vaccines Tell Us About Nucleic Acid Delivery
    Hadjiargyrou M
    Nucleic Acid Ther; 2021 Oct; 31(5):321-323. PubMed ID: 33960839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Nanoparticle-Mediated Delivery of mRNA Therapeutics and Vaccines.
    Swingle KL; Hamilton AG; Mitchell MJ
    Trends Mol Med; 2021 Jun; 27(6):616-617. PubMed ID: 33836968
    [No Abstract]   [Full Text] [Related]  

  • 7. Advancing mRNA Therapeutics: The Role and Future of Nanoparticle Delivery Systems.
    Li J; Zhang Y; Yang YG; Sun T
    Mol Pharm; 2024 Aug; 21(8):3743-3763. PubMed ID: 38953708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-liver mRNA Delivery.
    Loughrey D; Dahlman JE
    Acc Chem Res; 2022 Jan; 55(1):13-23. PubMed ID: 34859663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic modified messenger RNA for therapeutic applications.
    Gao M; Zhang Q; Feng XH; Liu J
    Acta Biomater; 2021 Sep; 131():1-15. PubMed ID: 34133982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal delivery strategies for nanoparticle-mediated mRNA delivery.
    Li X; Guo X; Hu M; Cai R; Chen C
    J Mater Chem B; 2023 Mar; 11(10):2063-2077. PubMed ID: 36794598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical and molecular biophysical techniques as substantial tools in the era of mRNA-based vaccine technology.
    Hussain A; Wang M; Yu D; Zhang J; Naseer QA; Ullah A; Milon Essola J; Zhang X
    Biomater Sci; 2024 Aug; 12(16):4117-4135. PubMed ID: 39016519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of drug delivery technologies in the success of COVID-19 vaccines: a perspective.
    Labouta HI; Langer R; Cullis PR; Merkel OM; Prausnitz MR; Gomaa Y; Nogueira SS; Kumeria T
    Drug Deliv Transl Res; 2022 Nov; 12(11):2581-2588. PubMed ID: 35290656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines.
    Wu Y; Yu S; de Lázaro I
    Nanoscale; 2024 Apr; 16(14):6820-6836. PubMed ID: 38502114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.
    Tenchov R; Bird R; Curtze AE; Zhou Q
    ACS Nano; 2021 Nov; 15(11):16982-17015. PubMed ID: 34181394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA delivery technologies: Toward clinical translation.
    Gómez-Aguado I; Rodríguez-Castejón J; Beraza-Millor M; Rodríguez-Gascón A; Del Pozo-Rodríguez A; Solinís MÁ
    Int Rev Cell Mol Biol; 2022; 372():207-293. PubMed ID: 36064265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
    Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
    Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of mRNA for regulating functions of immune cells.
    Shi J; Huang MW; Lu ZD; Du XJ; Shen S; Xu CF; Wang J
    J Control Release; 2022 May; 345():494-511. PubMed ID: 35337940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Status and Future Perspectives on MRNA Drug Manufacturing.
    Webb C; Ip S; Bathula NV; Popova P; Soriano SKV; Ly HH; Eryilmaz B; Nguyen Huu VA; Broadhead R; Rabel M; Villamagna I; Abraham S; Raeesi V; Thomas A; Clarke S; Ramsay EC; Perrie Y; Blakney AK
    Mol Pharm; 2022 Apr; 19(4):1047-1058. PubMed ID: 35238565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in mRNA vaccines.
    Li M; Wang Z; Xie C; Xia X
    Int Rev Cell Mol Biol; 2022; 372():295-316. PubMed ID: 36064266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.